[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Initiatives Bronchopneumopathie Chronique Obstructive (BPCO)\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":45},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100640734","prospective-dynamic-cohort-study-of-phenotypic-profiles-in-patients-with-chronic-obstructive-pulmonary-disease-100640734",false,"NCT07627763","Prospective Dynamic Cohort Study of Phenotypic Profiles in Patients With Chronic Obstructive Pulmonary Disease","Prospective Multicenter Dynamic Cohort Study to Evaluate Phenotypic Profiles of Subjects With Chronic Obstructive Pulmonary Disease (COPD-BPCO 2 Study)","COPD-BPCO 2","Inclusion Criteria:\n\nAge 18 years or older.\n\n* Stable COPD, defined as no exacerbation requiring treatment during the previous 4 weeks.\n* Confirmed COPD diagnosis based on post-bronchodilator FEV1\u002FFVC \\\u003C 70%\n\nExclusion Criteria:\n\n* Main diagnosis of bronchiectasis, asthma, or any other significant respiratory disease.\n* Patients under legal protection.\n* Pregnant women.","ALL","18 Years",{"count":20,"type":21},500,"ESTIMATED","OBSERVATIONAL","This prospective, multicenter, real-world observational cohort study will describe phenotypic profiles, patient characteristics, and treatments in adults with stable chronic obstructive pulmonary disease (COPD). The profiles observed in the current cohort will be compared with those of patients recruited between 2005 and 2018 in the previous COPD-BPCO 1 cohort. Patients will be followed for at least 3 years as part of routine care, with no study-specific visit or treatment.",[25],"COPD",[27,28,29,30,25,31],"quality of life","dyspnea","pulmonary function","exacerbations","CART","RECRUITING","2026-06-02",{"date":35,"type":36},"2026-06-04","ACTUAL",{"date":38,"type":36},"2026-05-01",{"date":40,"type":21},"2029-12-31",{"name":42,"class":43},"Initiatives Bronchopneumopathie Chronique Obstructive (BPCO)","OTHER",7,""]